CancerVax Biotech

🗓 Founded 2021👥 2 employees💰 Last funded Sep 2025
Biotechnology Research🌐 cancervax.com
Website LinkedIn
CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment Platform that will be customizable as an injection, to treat many types of cancer. Powered by artificial intelligence, our revolutionary approach DETECTS, MARKS, and KILLS only cancer cells using the body’s own immune system. Other immunotherapies have had very limited success trying to teach the immune system how to recognize cancer cells. Instead, we intend to make cancer cells look like a common disease that it already recognizes, such as measles, and “trick” the body into killing these “disguised” cancer cells with strength. We look forward to the day when treating cancer will be as simple as getting a shot.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in CancerVax Biotech?
CancerVax Biotech has 1 investors on record on gritt.io, 1 mid-stage.
When did CancerVax Biotech last raise funding?
The most recent investment in CancerVax Biotech recorded on gritt.io was in September 2025.
When was CancerVax Biotech founded?
CancerVax Biotech was founded in 2021.
What industry is CancerVax Biotech in?
CancerVax Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.